These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 33301778)

  • 1. Estimating the Backlog of Colonoscopy due to Coronavirus Disease 2019 and Comparing Strategies to Recover in Ontario, Canada.
    Tinmouth J; Dong S; Stogios C; Rabeneck L; Rey M; Dubé C;
    Gastroenterology; 2021 Mar; 160(4):1400-1402.e1. PubMed ID: 33301778
    [No Abstract]   [Full Text] [Related]  

  • 2. Positive Fecal Immunochemical Test or Cologuard in the Era of the Novel Coronavirus Disease-2019 Pandemic.
    Young PE; Tadros M; Mago S
    Gastroenterology; 2020 Dec; 159(6):2249-2250. PubMed ID: 32450148
    [No Abstract]   [Full Text] [Related]  

  • 3. Faecal immunochemical testing in the COVID-19 era: balancing risk and costs.
    Arasaradnam RP; Bhala N; Evans C; Greenaway J; Logan R; Penman I; Seward E; Singh B; Smith S; Stephenson JA; Waugh N;
    Lancet Gastroenterol Hepatol; 2020 Aug; 5(8):717-719. PubMed ID: 32526209
    [No Abstract]   [Full Text] [Related]  

  • 4. Impact of COVID-19 pandemic on fecal immunochemical test screening uptake and compliance to diagnostic colonoscopy.
    Cheng SY; Chen CF; He HC; Chang LC; Hsu WF; Wu MS; Chiu HM
    J Gastroenterol Hepatol; 2021 Jun; 36(6):1614-1619. PubMed ID: 33217055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of the COVID-19 Pandemic on Colorectal Cancer Screening: a Systematic Review.
    Mazidimoradi A; Tiznobaik A; Salehiniya H
    J Gastrointest Cancer; 2022 Sep; 53(3):730-744. PubMed ID: 34406626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Developing a prioritization model for endoscopy and colorectal cancer 2-week wait referrals during the COVID-19 pandemic-is faecal immunochemical testing the answer?
    Habib Bedwani N; English W; Coda S; Akinlade F; Elzayat I; Seward EW; Hayee B; Hanson M; Banerjee S
    Br J Surg; 2021 Jan; 108(1):e18-e19. PubMed ID: 33640923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FECAL OCCULT BLOOD: A COMPARISON OF CHEMICAL AND IMMUNOCHEMICAL TESTS.
    Borges LV; Mattar R; Silva JMKD; Silva ALWD; Carrilho FJ; Hashimoto CL
    Arq Gastroenterol; 2018; 55(2):128-132. PubMed ID: 30043860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Faecal immunochemical tests in the COVID-19 pandemic; safety-netting of patients with symptoms and low faecal haemoglobin concentration - can a repeat test be used?
    Benton SC; Fraser CG
    Ann Clin Biochem; 2021 May; 58(3):163-165. PubMed ID: 33016079
    [No Abstract]   [Full Text] [Related]  

  • 9. Resumption of endoscopy in the Galician colorectal cancer screening programme after the COVID-19 lock down: patient safety results.
    Peña-Rey I; Almazán R; Rodríguez-Camacho E; Cubiella J
    Rev Esp Enferm Dig; 2021 Feb; 113(2):119-121. PubMed ID: 33393333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reasons For Lack of Follow-up Colonoscopy Among Persons With A Positive Fecal Occult Blood Test Result: A Qualitative Study.
    Llovet D; Serenity M; Conn LG; Bravo CA; McCurdy BR; Dubé C; Baxter NN; Paszat L; Rabeneck L; Peters A; Tinmouth J
    Am J Gastroenterol; 2018 Dec; 113(12):1872-1880. PubMed ID: 30361625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimal use of colonoscopy and fecal immunochemical test for population-based colorectal cancer screening: a cost-effectiveness analysis using Japanese data.
    Sekiguchi M; Igarashi A; Matsuda T; Matsumoto M; Sakamoto T; Nakajima T; Kakugawa Y; Yamamoto S; Saito H; Saito Y
    Jpn J Clin Oncol; 2016 Feb; 46(2):116-25. PubMed ID: 26685321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impacts of the Coronavirus 2019 Pandemic on Gastrointestinal Endoscopy Volume and Diagnosis of Gastric and Colorectal Cancers: A Population-Based Study.
    Lui TKL; Leung K; Guo CG; Tsui VWM; Wu JT; Leung WK
    Gastroenterology; 2020 Sep; 159(3):1164-1166.e3. PubMed ID: 32425228
    [No Abstract]   [Full Text] [Related]  

  • 13. Nonmedical costs of colorectal cancer screening with the fecal occult blood test and colonoscopy.
    Heitman SJ; Au F; Manns BJ; McGregor SE; Hilsden RJ
    Clin Gastroenterol Hepatol; 2008 Aug; 6(8):912-917.e1. PubMed ID: 18534918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of time to colonoscopy after a positive fecal test result and fecal hemoglobin concentration with risk of advanced colorectal neoplasia.
    Kim NH; Lim JW; Kim S; Lim JY; Kim W; Park JH; Park DI; Sohn CI; Jung YS
    Dig Liver Dis; 2019 Apr; 51(4):589-594. PubMed ID: 30733186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A quantitative immunochemical fecal occult blood test for colorectal neoplasia.
    Levi Z; Rozen P; Hazazi R; Vilkin A; Waked A; Maoz E; Birkenfeld S; Leshno M; Niv Y
    Ann Intern Med; 2007 Feb; 146(4):244-55. PubMed ID: 17310048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fecal occult blood testing when colonoscopy capacity is limited.
    Wilschut JA; Habbema JD; van Leerdam ME; Hol L; Lansdorp-Vogelaar I; Kuipers EJ; van Ballegooijen M
    J Natl Cancer Inst; 2011 Dec; 103(23):1741-51. PubMed ID: 22076285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colorectal cancer in iron deficiency anemia with a positive result on immunochemical fecal occult blood.
    Nakama H; Zhang B; Fattah AS; Zhang X
    Int J Colorectal Dis; 2000 Nov; 15(5-6):271-4. PubMed ID: 11151429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of a New-generation Fecal Immunochemical Test (FIT) With Guaiac Fecal Occult Blood Test (gFOBT) in Detecting Colorectal Neoplasia Among Colonoscopy-referral Patients.
    Guimarães DP; Fregnani JH; Reis RM; Taveira LN; Scapulatempo-Neto C; Matsushita M; Silva SRM; Oliveira CZ; Longatto-Filho A; Eklund C; Paloheimo L; Mauad E; Suovaniemi O; Syrjänen K
    Anticancer Res; 2019 Jan; 39(1):261-269. PubMed ID: 30591467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colorectal cancer referrals during the COVID-19 pandemic - a model for the faster diagnosis standard?
    Barrett K; Habib Bedwani N; Arya S; Bhargava A
    Br J Surg; 2020 Oct; 107(11):e531-e532. PubMed ID: 32871025
    [No Abstract]   [Full Text] [Related]  

  • 20. Molecular-based Alternatives for Colorectal Cancer Screening during the COVID-19 Pandemic.
    Dockter AG; Angelos GC
    Surg Technol Int; 2020 May; 36():143-147. PubMed ID: 32347964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.